GSK 650394 Inhibits Osteoclasts Differentiation and Prevents Bone Loss via Promoting the Activities of Antioxidant Enzymes In Vitro and In Vivo
Author(s) -
LinYu Jin,
Shicheng Huo,
Chen Guo,
Hai-Ying Liu,
Shuai Xu,
XinFeng Li
Publication year - 2022
Publication title -
oxidative medicine and cellular longevity
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.494
H-Index - 93
eISSN - 1942-0900
pISSN - 1942-0994
DOI - 10.1155/2022/3458560
Subject(s) - rankl , osteoclast , osteoblast , chemistry , in vivo , bone resorption , osteolysis , microbiology and biotechnology , downregulation and upregulation , activator (genetics) , mapk/erk pathway , signal transduction , osteoporosis , intracellular , in vitro , cancer research , endocrinology , biochemistry , receptor , biology , medicine , gene , surgery
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom